Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells.

Abstract:

:Cationic liposomes provide a means to introduce genes into cells both ex vivo and in vivo. In the past few years their use has been described in several tissues, e.g. lungs, liver, endothelium, brain. In this study we evaluated a commercially available poly-cationic liposome formulation in delivering a reporter gene into cultured myogenic cell lines from mouse and rat, and primary fetal human myoblasts. We also examined the effect of serum on liposome-mediated transfection and designed a new procedure to enhance transfection efficiency, based on the pre-condensation of plasmid DNA with polylysine. Polylysine pre-condensation was particularly effective when transfecting the cells in the presence of serum, a finding that could be significant for in vivo transfections.

journal_name

Gene Ther

journal_title

Gene therapy

authors

Vitiello L,Chonn A,Wasserman JD,Duff C,Worton RG

subject

Has Abstract

pub_date

1996-05-01 00:00:00

pages

396-404

issue

5

eissn

0969-7128

issn

1476-5462

journal_volume

3

pub_type

杂志文章
  • Adenoviral vectors for in vivo gene delivery to oligodendrocytes: transgene expression and cytopathic consequences.

    abstract::Replication defective viral vectors provide a potentially useful means of gene transfer to oligodendrocytes and thus for studying the pathogenesis of white matter disease. In this study we have examined the expression pattern of E1/E3 deleted adenoviral vectors expressing the reporter gene LacZ (AdlacZ) as a means of ...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3300971

    authors: Franklin Rm,Quick Mm,Haase G

    更新日期:1999-08-01 00:00:00

  • Generation of human TRIM5alpha mutants with high HIV-1 restriction activity.

    abstract::Rhesus macaque tripartite motif (TRIM)5alpha potently inhibits early stages of human immunodeficiency virus (HIV)-1 replication, while the human orthologue has little effect on this virus. We used PCR-based random mutagenesis to construct a large library of human TRIM5alpha variants containing mutations in the PRYSPRY...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.40

    authors: Pham QT,Bouchard A,Grütter MG,Berthoux L

    更新日期:2010-07-01 00:00:00

  • Expression of beta-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system.

    abstract::Sindbis virus expression has been used for in vitro investigations of antigen processing, presentation and epitope mapping. The recent development of a replication-deficient recombinant Sindbis virus expression vector has made in vivo expression possible with minimal pathogenic risk. Advantages of Sindbis virus over o...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3300458

    authors: Altman-Hamamdzic S,Groseclose C,Ma JX,Hamamdzic D,Vrindavanam NS,Middaugh LD,Parratto NP,Sallee FR

    更新日期:1997-08-01 00:00:00

  • Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.

    abstract::Replication defective vectors derived from simple retroviruses or the more complex genomes of lentiviruses continue to offer the advantages of long-term expression, cell and tissue specific tropism, and large packaging capacity for the delivery of therapeutic genes. The occurrence of adverse events caused by insertion...

    journal_title:Gene therapy

    pub_type: 杂志文章,评审

    doi:10.1038/sj.gt.3302570

    authors: Sinn PL,Sauter SL,McCray PB Jr

    更新日期:2005-07-01 00:00:00

  • Intracellular rate-limiting steps of gene transfer using glycosylated polylysines in cystic fibrosis airway epithelial cells.

    abstract::To identify the intracellular barriers to efficient gene transfer, we studied the intracellular trafficking of biotinylated plasmid DNA complexed with either fluorescein-conjugated lactosylated or mannosylated polylysine by confocal microscopy. Both are known to be taken up by cystic fibrosis airway epithelial cells (...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3301768

    authors: Grosse S,Tremeau-Bravard A,Aron Y,Briand P,Fajac I

    更新日期:2002-08-01 00:00:00

  • Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus.

    abstract::The current therapies to treat hepatitis B virus (HBV) infection are limited. Recently, clustered regularly interspaced short palindromic repeat (CRISPR) systems, originally identified in bacteria and archaea, have been found to consist of an RNA-based adaptive immune system that degrades complimentary sequences of in...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2015.2

    authors: Zhen S,Hua L,Liu YH,Gao LC,Fu J,Wan DY,Dong LH,Song HF,Gao X

    更新日期:2015-05-01 00:00:00

  • Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo.

    abstract::Regulated expression of therapeutic genes is required for long-term gene therapy applications for many disorders. Here we describe a doxycycline (dox)-regulated lentiviral vector system consisting of two HIV-1-based self-inactivating viruses. One of the vectors is constitutively expressing a novel improved version of ...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3301889

    authors: Koponen JK,Kankkonen H,Kannasto J,Wirth T,Hillen W,Bujard H,Ylä-Herttuala S

    更新日期:2003-03-01 00:00:00

  • Bidirectional promoter interference between two widely used internal heterologous promoters in a late-generation lentiviral construct.

    abstract::Gene transfer vectors encoding two or more genes are potentially powerful research tools and are poised to play an increasingly important role in gene therapy applications. Common strategies employed to express more than one transgene per vector include the use of multiple promoters, internal ribosome entry site (IRES...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3303105

    authors: Curtin JA,Dane AP,Swanson A,Alexander IE,Ginn SL

    更新日期:2008-03-01 00:00:00

  • Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by intramuscular injection of plasmid DNA.

    abstract::We report on systemic delivery and long-term biological effects of apolipoprotein E (apoE) obtained by intramuscular (i.m.) plasmid DNA injection. ApoE plays an important role in lipoprotein catabolism and apoE knock-out mice develop severe hypercholesterolemia and diffuse atherosclerosis. We have injected apoE-defici...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3301310

    authors: Rinaldi M,Catapano AL,Parrella P,Ciafrè SA,Signori E,Seripa D,Uboldi P,Antonini R,Ricci G,Farace MG,Fazio VM

    更新日期:2000-11-01 00:00:00

  • β1-Na(+),K(+)-ATPase gene therapy upregulates tight junctions to rescue lipopolysaccharide-induced acute lung injury.

    abstract::Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are associated with diverse disorders and characterized by disruption of the alveolar-capillary barrier, leakage of edema fluid into the lung, and substantial inflammation leading to acute respiratory failure. Gene therapy is a potentially powerful...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2016.19

    authors: Lin X,Barravecchia M,Kothari P,Young JL,Dean DA

    更新日期:2016-06-01 00:00:00

  • Efficient gene delivery to human and rodent islets with double-stranded (ds) AAV-based vectors.

    abstract::Transplantation of allogeneic pancreatic islets is an effective approach to treat type 1 diabetes. To bypass the need for systemic administration of immunosuppression drugs following transplantation, approaches to genetically modify allogeneic islets to express anti-inflammatory, immunosuppressive, or antiapoptotic pr...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3302530

    authors: Rehman KK,Wang Z,Bottino R,Balamurugan AN,Trucco M,Li J,Xiao X,Robbins PD

    更新日期:2005-09-01 00:00:00

  • Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography.

    abstract::To elucidate further the potential of a Semliki Forest virus (SFV) vector in vivo for gene therapy, we constructed a vector, SFV-IL12, to transfer murine IL-12 genes into tumors. A single intratumoral injection of established B16 murine melanoma with SFV-IL12 resulted in a significant inhibition of tumor growth, while...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3300841

    authors: Asselin-Paturel C,Lassau N,Guinebretière JM,Zhang J,Gay F,Bex F,Hallez S,Leclere J,Peronneau P,Mami-Chouaib F,Chouaib S

    更新日期:1999-04-01 00:00:00

  • Co-injection of adenovirus expressing CTLA4-Ig prolongs adenovirally mediated lacZ reporter gene expression in the mouse retina.

    abstract::There is growing interest in gene delivery to the eye in order to develop gene therapy for the many ocular disorders which may be amenable to this approach. To date, recombinant adenoviruses (AV) have been the main vector used for gene delivery to anterior and posterior segments in animal models. As with delivery to o...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3300761

    authors: Ali RR,Reichel MB,Byrnes AP,Stephens CJ,Thrasher AJ,Baker D,Hunt DM,Bhattacharya SS

    更新日期:1998-11-01 00:00:00

  • Gene therapy in transplantation in the year 2000: moving towards clinical applications?

    abstract::Transplantation faces several major obstacles that could be overcome by expression of immunomodulatory proteins through application of gene therapy techniques. Gene therapy strategies to prolong graft survival involve gene transfer of immunosuppressive or graft-protecting molecules. Very promising results have been ob...

    journal_title:Gene therapy

    pub_type: 杂志文章,评审

    doi:10.1038/sj.gt.3301083

    authors: Guillot C,Le Mauff B,Cuturi MC,Anegon I

    更新日期:2000-01-01 00:00:00

  • Gene doping detection: evaluation of approach for direct detection of gene transfer using erythropoietin as a model system.

    abstract::As clinical gene therapy has progressed toward realizing its potential, concern over misuse of the technology to enhance performance in athletes is growing. Although 'gene doping' is banned by the World Anti-Doping Agency, its detection remains a major challenge. In this study, we developed a methodology for direct de...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.49

    authors: Baoutina A,Coldham T,Bains GS,Emslie KR

    更新日期:2010-08-01 00:00:00

  • Efficient delivery of angiostatin K1-5 into tumors following insertion of an NGR peptide into adenovirus capsid.

    abstract::Adenovirus (Ad)-mediated delivery of anti-angiogenic molecules into tumors constitutes an appealing approach for growth inhibition. However, lack of expression on tumors of Ad receptors leads to weak tumor transduction. Therefore, to provide Ad with a new entry pathway into tumors, an NGR peptide was inserted into eit...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2009.97

    authors: Jullienne B,Vigant F,Muth E,Chaligné R,Bouquet C,Giraudier S,Perricaudet M,Benihoud K

    更新日期:2009-12-01 00:00:00

  • Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450.

    abstract::The prognosis of pancreatic adenocarcinoma is poor and current treatment ineffective. A novel treatment strategy is described here using a mouse model system for pancreatic cancer. Cells that have been genetically modified to express the cytochrome P450 2B1 enzyme are encapsulated in cellulose sulphate and implanted i...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3300671

    authors: Löhr M,Müller P,Karle P,Stange J,Mitzner S,Jesnowski R,Nizze H,Nebe B,Liebe S,Salmons B,Günzburg WH

    更新日期:1998-08-01 00:00:00

  • Expression of HSV-1 receptors in EBV-associated lymphoproliferative disease determines susceptibility to oncolytic HSV.

    abstract::Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disease (LPD) after hematopoietic stem cell or solid organ transplantation remains a life-threatening complication. Expression of the virus-encoded gene product, EBER, has been shown to prevent apoptosis via blockade of PKR activation. As PKR is a major ce...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2012.93

    authors: Wang PY,Currier MA,Hansford L,Kaplan D,Chiocca EA,Uchida H,Goins WF,Cohen JB,Glorioso JC,van Kuppevelt TH,Mo X,Cripe TP

    更新日期:2013-07-01 00:00:00

  • A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia.

    abstract::Complexes of DNA and cationic lipid offer potential advantages for gene transfer to airway epithelia. However, we found that application of DNA-lipid (DMRIE-DOPE) complexes to primary cultures of human ciliated airway epithelia or explants of rabbit trachea generated only low levels of gene transfer. In contrast, when...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3300524

    authors: Fasbender A,Zabner J,Zeiher BG,Welsh MJ

    更新日期:1997-11-01 00:00:00

  • HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene.

    abstract::In vivo approaches to liver gene therapy will require restriction of transgene expression to hepatocytes. Since targeting of viral vectors exclusively to the liver is not easy to achieve, use of liver-specific promoters for driving expression of therapeutic genes is an interesting alternative. We have shown previously...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:

    authors: Sandig V,Löser P,Lieber A,Kay MA,Strauss M

    更新日期:1996-11-01 00:00:00

  • Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells.

    abstract::Glioblastoma multiforme (GBM) is one of the most formidable brain tumors with a mean survival period of approximately 12 months. To date, a combination of radiotherapy and chemotherapy with an oral alkylating agent, temozolomide (TMZ), has been used as first-line therapy for glioma. However, the efficacy of chemothera...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.88

    authors: Kato T,Natsume A,Toda H,Iwamizu H,Sugita T,Hachisu R,Watanabe R,Yuki K,Motomura K,Bankiewicz K,Wakabayashi T

    更新日期:2010-11-01 00:00:00

  • Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells.

    abstract::A persistent obstacle in the use of vector systems for gene therapy has been the inability to attain high-level expression of the target gene in primary cells in vivo. The MFG retroviral vector was designed to yield improved expression over the widely used N2 or LN vectors; however, the molecular basis for this effect...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:

    authors: Krall WJ,Skelton DC,Yu XJ,Riviere I,Lehn P,Mulligan RC,Kohn DB

    更新日期:1996-01-01 00:00:00

  • Human PBMC-derived dendritic cells transduced with an adenovirus vectorinduce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro.

    abstract::Dendritic cells (DC) are among the most potent antigen-presenting cells known and play an important role in the initiation of antigen-specific T-lymphocyte responses. Several recent studies have demonstrated that DC expressing vector-encoded tumor-associated antigens can induce protective and therapeutic immunity in m...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3300899

    authors: Diao J,Smythe JA,Smyth C,Rowe PB,Alexander IE

    更新日期:1999-05-01 00:00:00

  • Rapid identification of viable retrovirus-transduced cells using the green fluorescent protein as a marker.

    abstract::Various methods for determining the expression of the beta-galactosidase (beta-gal) gene after retroviral transduction were compared as a means to assess retroviral titre. To allow better comparison, different retroviral vectors were constructed carrying two mutants of the green fluorescent protein and assessed as sen...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3300519

    authors: Klein D,Indraccolo S,von Rombs K,Amadori A,Salmons B,Günzburg WH

    更新日期:1997-11-01 00:00:00

  • Virally expressed connexin26 restores gap junction function in the cochlea of conditional Gjb2 knockout mice.

    abstract::Mutations in GJB2, which codes for the gap junction (GJ) protein connexin26 (Cx26), are the most common causes of human nonsyndromic hereditary deafness. We inoculated modified adeno-associated viral (AAV) vectors into the scala media of early postnatal conditional Gjb2 knockout mice to drive exogenous Cx26 expression...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2013.59

    authors: Yu Q,Wang Y,Chang Q,Wang J,Gong S,Li H,Lin X

    更新日期:2014-01-01 00:00:00

  • Cyclodextrin mediated delivery of NF-κB and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro.

    abstract::Prostate cancer is the most common cancer in men of the western world. To date, no effective treatment exists for metastatic prostate cancer and consequently, there is an urgent need to develop new and improved therapeutics. In recent years, the therapeutic potential of RNA interference (RNAi) has been extensively exp...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2015.50

    authors: Evans JC,McCarthy J,Torres-Fuentes C,Cryan JF,Ogier J,Darcy R,Watson RW,O'Driscoll CM

    更新日期:2015-10-01 00:00:00

  • Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency.

    abstract::To test whether fast-acting, self-complimentary (sc), adeno-associated virus-mediated RPE65 expression prevents cone degeneration and/or restores cone function, we studied two mouse lines: the Rpe65-deficient rd12 mouse and the Rpe65-deficient, rhodopsin null ('that is, cone function-only') Rpe65(-/-)::Rho(-/-) mouse....

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/gt.2010.29

    authors: Pang J,Boye SE,Lei B,Boye SL,Everhart D,Ryals R,Umino Y,Rohrer B,Alexander J,Li J,Dai X,Li Q,Chang B,Barlow R,Hauswirth WW

    更新日期:2010-07-01 00:00:00

  • Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery.

    abstract::Recombinant Autographa californica multiple nuclear polyhedrosis viruses (AcMNPV) have recently been shown to transduce mammalian cells in vitro. Since baculoviruses offer many advantages over viruses currently used in gene therapy, we have tested them for in vivo gene transfer by constructing a baculovirus bearing a ...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3301269

    authors: Airenne KJ,Hiltunen MO,Turunen MP,Turunen AM,Laitinen OH,Kulomaa MS,Ylä-Herttuala S

    更新日期:2000-09-01 00:00:00

  • Redirecting adenovirus to pulmonary endothelium by cationic liposomes.

    abstract::Somatic gene transfer to the pulmonary endothelium may be a useful strategy for modifying the phenotype of endothelium and/or vascular smooth muscle in disorders such as primary pulmonary hypertension, ARDS or pulmonary metastatic disease. Adenoviral (Ad) vectors, although highly efficient in liver gene transfer, have...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3301636

    authors: Ma Z,Mi Z,Wilson A,Alber S,Robbins PD,Watkins S,Pitt B,Li S

    更新日期:2002-02-01 00:00:00

  • Bypassing tumor-specific and bispecific antibodies: triggering of antitumor immunity by expression of anti-FcgammaR scFv on cancer cell surface.

    abstract::We have developed a novel immunostimulatory molecule against tumor cells, composed of an anti-FcgammaRIII (CD16) scFv fused to the platelet-derived growth factor receptor (PDGFR) transmembrane region. This fusion molecule was stably expressed on the tumor cell surface and retained the ability of the parental antibody ...

    journal_title:Gene therapy

    pub_type: 杂志文章

    doi:10.1038/sj.gt.3301575

    authors: Gruel N,Fridman WH,Teillaud JL

    更新日期:2001-11-01 00:00:00